TBThomas Blumenthal

Thomas Blumenthal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Blumenthal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Erika L. Lasda

    Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA

    3 shared publications
  • Alfonso Garrido-Lecca

    A Department of Molecular, Cellular, and Developmental Biology , University of Colorado , Boulder , CO , USA

    2 shared publications
  • Margaret MacMorris

    Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045; and

    2 shared publications
  • Mary Ann Allen

    Department of Molecular, Cellular, and Developmental Biology, University of Colorado at Boulder, Colorado 80309, USA

    2 shared publications
  • Tassa Saldi

    A Department of Molecular, Cellular, and Developmental Biology , University of Colorado , Boulder , CO , USA

    2 shared publications
  • Alison Larsen

    Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado 80045, USA

    1 shared publication

Latest Publications

  • Localization of RNAPII and 3′ end formation factor CstF subunits onC. elegansgenes and operons

    by Alfonso Garrido-Lecca, Tassa Saldi, Thomas Blumenthal

    Transcription termination is mechanistically coupled to pre-mRNA 3′ end formation to prevent transcription much beyond the gene 3′ end. C. elegans, however, engages in polycistronic transcription of operons in which 3′ end formation between genes is not accompanied by termination. We have performed RNA polymerase II (RNAPII) and CstF ChIP-seq experiments to investigate at a genome-wide level how RNAPII can transcribe through multiple poly-A signals without causing termination. Our data shows that transcription proceeds in some ways as if operons were composed of multiple adjacent single genes. Total RNAPII shows a small peak at the promoter of the gene cluster and a much larger peak at 3′ ends. These 3′ peaks coincide with maximal phosphorylation of Ser2 within the C-terminal domain (CTD) of RNAPII and maximal localization of the 3′ end formation factor CstF. This pattern occurs at all 3′ ends including those at internal sites in operons where termination does not occur. Thus the normal mechanism of 3′ end formation does not always result in transcription termination. Furthermore, reduction of CstF50 by RNAi did not substantially alter the pattern of CstF64, total RNAPII, or Ser2 phosphorylation at either internal or terminal 3′ ends. However, CstF50 RNAi did result in a subtle reduction of CstF64 binding upstream of the site of 3′ cleavage, suggesting that the CstF50/CTD interaction may facilitate bringing the 3′ end machinery to the transcription complex.


  • Open Access

    Operon and non-operon gene clusters in the C. elegans genome

    by Thomas Blumenthal

    Nearly 15% of the ~20,000 C. elegans genes are contained in operons, multigene clusters controlled by a single promoter. The vast majority of these are of a type where the genes in the cluster are ~100 bp apart and the pre-mRNA is processed by 3' end formation accompanied by trans-splicing. A spliced leader, SL2, is specialized for operon processing. Here we summarize current knowledge on several variations on this theme including: (1) hybrid operons, which have additional promoters between genes; (2) operons with exceptionally long (> 1 kb) intercistronic regions; (3) operons with a second 3' end formation site close to the trans-splice site; (4) alternative operons, in which the exons are sometimes spliced as a single gene and sometimes as two genes; (5) SL1-type operons, which use SL1 instead of SL2 to trans-splice and in which there is no intercistronic space; (6) operons that make dicistronic mRNAs; and (7) non-operon gene clusters, in which either two genes use a single exon as the 3' end of one and the 5' end of the next, or the 3' UTR of one gene serves as the outron of the next. Each of these variations is relatively infrequent, but together they show a remarkable variety of tight-linkage gene arrangements in the C. elegans genome.


  • Split Genes: Another Surprise from Giardia

    by Thomas Blumenthal


  • SL Trans-Splicing in a Caenorhabditis elegans In Vitro Extract

    by Erika L. Lasda, Scott Kuersten, Thomas Blumenthal

    INTRODUCTION: Caenorhabditis elegans is one of a number of organisms in which spliced leader (SL) trans-splicing contributes to the maturation of many pre-mRNA transcripts. C. elegans and related nematodes have two distinct classes of SL RNA—SL1 and SL2—that are used differentially for different classes of pre-mRNAs; namely, SL1 trans-splices non-operon genes and first genes in operons, while SL2 splices downstream operon genes. In vitro RNA splicing has previously been used to analyze substrate RNA sequences, required protein and RNA factors, and splicing mechanisms in a variety of systems. This protocol describes an in vitro splicing assay using C. elegans extract that promotes both cis- and trans-splicing of substrate RNAs. It has the ability to correctly specify and detect SL1 versus SL2 trans-splicing. Operon-derived substrates splice SL2, while substrates with an intron-like sequence followed by a 3′ trans-splice site (outron) splice SL1. Unlabeled T7-transcribed RNA substrates are incubated with crude embryonic extract and trans-spliced by endogenous SL small nuclear ribonucleoproteins (snRNPs). Spliced RNA is analyzed using a reverse transcriptase polymerase chain reaction (RT-PCR). Specific RT and PCR primers ensure detection of trans-spliced substrate RNA and allow a means to distinguish between SL1 and SL2 trans-spliced products. Substrates containing introns are also cis-spliced. All reaction products are ATP-dependent.


  • Trans‐splicing

    by Erika L. Lasda, Thomas Blumenthal

    Trans‐splicing is the joining together of portions of two separate pre‐mRNA molecules. The two distinct categories of spliceosomal trans‐splicing are genic trans‐splicing, which joins exons of different pre‐mRNA transcripts, and spliced leader (SL) trans‐splicing, which involves an exon donated from a specialized SL RNA. Both depend primarily on the same signals and components as cis‐splicing. Genic trans‐splicing events producing protein‐coding mRNAs have been described in a variety of organisms, including Caenorhabditis elegans and Drosophila. In mammalian cells, genic trans‐splicing can be associated with cancers and translocations. SL trans‐splicing has mainly been studied in nematodes and trypanosomes, but there are now numerous and diverse phyla (including primitive chordates) where this type of trans‐splicing has been detected. Such diversity raises questions as to the evolutionary origin of the process. Another intriguing question concerns the function of trans‐splicing, as operon resolution can only account for a small proportion of the total amount of SL trans‐splicing. WIREs RNA 2011 2 417–434 DOI: 10.1002/wrna.71This article is categorized under: RNA Processing > Splicing Mechanisms RNA Processing > Splicing Regulation/Alternative Splicing


  • Open Access

    A global analysis of C. elegans trans-splicing

    by Mary Ann Allen, LaDeana W. Hillier, Robert H. Waterston, Thomas Blumenthal

    Trans-splicing of one of two short leader RNAs, SL1 or SL2, occurs at the 5′ ends of pre-mRNAs of many C. elegans genes. We have exploited RNA-sequencing data from the modENCODE project to analyze the transcriptome of C. elegans for patterns of trans-splicing. Transcripts of ∼70% of genes are trans-spliced, similar to earlier estimates based on analysis of far fewer genes. The mRNAs of most trans-spliced genes are spliced to either SL1 or SL2, but most genes are not trans-spliced to both, indicating that SL1 and SL2 trans-splicing use different underlying mechanisms. SL2 trans-splicing occurs in order to separate the products of genes in operons genome wide. Shorter intercistronic distance is associated with greater use of SL2. Finally, increased use of SL1 trans-splicing to downstream operon genes can indicate the presence of an extra promoter in the intercistronic region, creating what has been termed a “hybrid” operon. Within hybrid operons the presence of the two promoters results in the use of the two SL classes: Transcription that originates at the promoter upstream of another gene creates a polycistronic pre-mRNA that receives SL2, whereas transcription that originates at the internal promoter creates transcripts that receive SL1. Overall, our data demonstrate that >17% of all C. elegans genes are in operons.


  • Identification of transcription start sites of trans-spliced genes: Uncovering unusual operon arrangements

    by J. Jason Morton, Thomas Blumenthal

    In Caenorhabditis elegans, the transcripts of many genes are trans-spliced to an SL1 spliced leader, a process that removes the RNA extending from the transcription start site to the trans-splice site, thereby making it difficult to determine the position of the promoter. Here we use RT-PCR to identify promoters of trans-spliced genes. Many genes in C. elegans are organized in operons where genes are closely clustered, typically separated by only ∼100 nucleotides, and transcribed by an upstream promoter. The transcripts of downstream genes are trans-spliced to an SL2 spliced leader. The polycistronic precursor RNA is processed into individual transcripts by 3′ end formation and trans-splicing. Although the SL2 spliced leader does not appear to be used for other gene arrangements, there is a relatively small number of genes whose transcripts are processed by SL2 but are not close to another gene in the same orientation. Although these genes do not appear to be members of classical C. elegans operons, we investigated whether these might represent unusual operons with long spacing or a different, nonoperon mechanism for specifying SL2 trans-splicing. We show transcription of the entire region between the SL2 trans-spliced gene and the next upstream gene, sometimes several kilobases distant, suggesting that these represent exceptional operons. We also report a second type of atypical “alternative” operon, in which 3′ end formation and trans-splicing by SL2 occur within an intron. In this case, the processing sometimes results in a single transcript, and sometimes in two separate mRNAs.


  • RNA Polymerase II C-Terminal Domain Phosphorylation Patterns in Caenorhabditis elegans Operons, Polycistronic Gene Clusters with Only One Promoter

    by Alfonso Garrido-Lecca, Thomas Blumenthal

    The heptad repeat of the RNA polymerase II (RNAPII) C-terminal domain is phosphorylated at serine 5 near gene 5' ends and serine 2 near 3' ends in order to recruit pre-mRNA processing factors. Ser-5(P) is associated with gene 5' ends to recruit capping enzymes, whereas Ser-2(P) is associated with gene 3' ends to recruit cleavage and polyadenylation factors. In the gene clusters called operons in Caenorhabditis elegans, there is generally only a single promoter, but each gene in the operon forms a 3' end by the usual mechanism. Although downstream operon genes have 5' ends, they receive their caps by trans splicing rather than by capping enzymes. Thus, they are predicted to not need Ser-5 phosphorylation. Here we show by RNAPII chromatin immunoprecipitation (ChIP) that internal operon gene 5' ends do indeed lack Ser-5(P) peaks. In contrast, Ser-2(P) peaks occur at each mRNA 3' end, where the 3'-end formation machinery binds. These results provide additional support for the idea that the serine phosphorylation of the C-terminal domain (CTD) serves to bring RNA-processing enzymes to the transcription complex. Furthermore, these results provide a novel demonstration that genes in operons are cotranscribed from a single upstream promoter.


  • Polycistronic pre-mRNA processing in vitro: snRNP and pre-mRNA role reversal in trans-splicing

    by Erika L. Lasda, Mary Ann Allen, Thomas Blumenthal

    Spliced leader (SL) trans-splicing in Caenorhabditis elegans attaches a 22-nucleotide (nt) exon onto the 5′ end of many mRNAs. A particular class of SL, SL2, splices mRNAs of downstream operon genes. Here we use an embryonic extract-based in vitro splicing system to show that SL2 specificity information is encoded within the polycistronic pre-mRNA, and that trans-splicing specificity is recapitulated in vitro. We define an RNA sequence required for SL2 trans-splicing, the U-rich (Ur) element, through mutational analysis and bioinformatics as a short stem–loop followed by a sequence motif, UAYYUU, located ∼50 nt upstream of the trans-splice site. Furthermore, this element is predicted in intercistronic regions of numerous operons of C. elegans and other species that use SL2 trans-splicing. We propose that the UAYYUU motif hybridizes with the 5′ splice site on the SL2 RNA to recruit the SL to the pre-mRNA. In this way, the UAYYUU motif in the pre-mRNA would serve an analogous function to the similar sequence in the U1 snRNA, which binds to the 5′ splice site of introns, effectively reversing the roles of snRNP and pre-mRNA in trans-splicing.


  • The Cart Before the Horse

    by Janet D. Rowley, Thomas Blumenthal

    Chimeric RNAs, transcribed from malignancy-associated chromosomal translocations, can also arise from RNA trans-splicing in normal cells.